Alternatives
Alternatives to Clariscan 37690 mg/100 mL injection
2 other presentations of Gadoterate 37690 mg/100 mL injection
There are 2 alternatives to this medicine in the catalogue: the same active ingredient (Gadoterate), strength (37690 mg/100 mL) and dosage form (injection) from 2 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Clariscan 37690 mg/100 mL injectionThis pageIntravenous | GE Healthcare | US FDA | 10 bottles of 100 mL | Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Should solidification occur in the bottle because of exposure to the cold, bring Clariscan to room temperature before use. If allowed to stand at room temperature for a minimum of 90 minutes, Clariscan should return to a clear, colorless to yellow solution. | On request | — | Available on request |
| Gadoterate 37690 mg/100 mL injectionIntravenous | — | US FDA | 6 cartons of 100 mL, 6 vials of 100 mL | Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F). Should solidification occur in the vial because of exposure to the cold, bring Gadoterate Meglumine Injection, USP to room temperature before use. If allowed to stand at room temperature for a minimum of 90 minutes, Gadoterate Meglumine Injection, USP should return to a clear, colorless to yellow solution. | On request | — | Available on request |
| Dotarem 37690 mg/100 mL injectionIntravenous | Guerbet | US FDA | 6 vials of 100 mL, 6 vials of 100 mL | Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Should solidification occur in the vial because of exposure to the cold, bring DOTAREM to room temperature before use. If allowed to stand at room temperature for a minimum of 90 minutes, DOTAREM should return to a clear, colorless to yellow solution. | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Clariscan 37690 mg/100 mL injectionNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.